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OBJECTIVE: To perform a descriptive analysis of preterm premature rupture of membranes (PPROM) cases
attended in a tertiary hospital.
METHOD: Retrospective analysis of medical records and laboratory tests of patients admitted to a Brazilian
tertiary hospital between 2006 and 2011, with a confirmed diagnosis of PPROM and gestational age (GA) at
delivery o37 weeks.
RESULTS: A total of 299 pregnant women were included in the study. Nine patients evolved to abortion, and
290 pregnant women remained for the final analysis. There was initial diagnostic doubt in 17.6% of the cases.
The oligohydramnios rate [amniotic fluid index (AFI) o5] was 27.9% on admission. Chorioamnionitis was
initially diagnosed in 10.8% of the patients and was retrospectively confirmed in 22.9% of the samples.
The latency period had a mean of 9.1 days. The main reasons for interruption were premature labor (55.2%),
GA X36 weeks (27.2%), and fetal distress (6.9%). The delivery method was cesarean section in 55% of cases.
The mean birth weight was 2,124 grams, and 67% of the neonates had a low birth weight (o2500 g). The GA
at delivery averaged 33.5 weeks. The stillbirth rate was 5.3%, and the early neonatal mortality rate was 5.6%.
There were complications at delivery in 18% of mothers.
CONCLUSION: In one of the few Brazilian reports on the epidemiological profile of PPROM, with GA until
37 weeks and intercurrences generally excluded from assessments (such as twinning and fetal malformations),
there is a favorable evolution, with an acceptable rate of complications.
KEYWORDS: Fetal Membranes; Premature Rupture; Pregnancy Outcome; Pregnancy Complications; Obstetric
Labor; Premature; Infant; Newborn; Perinatal Death.
’ INTRODUCTION
Premature rupture of membranes (PROM), defined as
rupture of the amnion and chorion before labor, represents a
serious public health problem when it occurs before the 37th
gestational week. The so-called preterm premature rupture
of membranes (PPROM) affects approximately 2-3% of preg-
nant women (1), accounting for approximately one-third of
premature births, with rates of 32.6% in the United States (2)
and 28.7% in Brazil (3). According to some authors, PPROM
is the most common intercurrence in prematurity (4).
PPROM generally presents a great dilemma for the
attending physician, who must determine the best time for
intervention by balancing the risks of prematurity on the
one hand and the risks of intra-amniotic infection and
intrauterine fetal death on the other. Despite great con-
troversy regarding the optimal clinical conduct (5), approxi-
mately half of the infants of women with PPROM tend
to be born within a week and face the risks inherent to pre-
maturity (1).
This scenario is more dramatic in developing countries,
where high rates of prematurity are associated with neonatal
care conditions and vacancies in neonatal intensive care units
that are less than ideal (6). Despite this high prevalence, and
especially in Brazil, there are few scientific publications
regarding PPROM, especially in terms of the epidemiology,
management and complications of this obstetric pathology,
and these publications lack a complete description of
patients with late prematurity or cases of twins and fetal
malformations (7-12). Against this background, we aimed to
perform a detailed and critical analysis of our experiences
with PPROM, considering its demographic, obstetric and
neonatal characteristics and main complications, at aDOI: 10.6061/clinics/2019/e1231
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Brazilian tertiary service, with the intention of seeking more
appropriate approaches in such cases.
’ MATERIALS AND METHODS
We performed a retrospective analysis of the PPROM cases
admitted to the Obstetrics Clinic of the Hospital das Clinicas
of FMUSP, São Paulo, Brazil, between 2006 and 2011 that met
the following inclusion criteria: a confirmed diagnosis of
PPROM; gestational age (GA) at delivery o37 weeks; and
childbirth data available. The patients were selected from the
computer system used on the ward (Access MS), and medi-
cal records and laboratory tests were verified using the
electronic platform of the Central Laboratory of Hospital das
Clinicas.
The patients were treated according to the protocol of the
Hospital das Clinicas of the FMUSP obstetrics clinic, which is
based on a previously published protocol (13). This protocol
includes expectant management up to 36 weeks and daily
assessments of fetal vitality, including the quantification of
the amount of amniotic fluid according to the technique of
Phelan et al. (14) and monitoring of respiratory movements
according to the technique of Manning et al. (15), as well as
laboratory evaluations of leukocytes and C-reactive protein
(CRP) every two days. Follow-up was continued until the
36th week of pregnancy, at which time, gestation was inter-
rupted. The pregnancy was interrupted before then only in
cases of preterm labor (which was not inhibited), altered fetal
vitality or chorioamnionitis. A diagnosis of chorioamnionitis
was assumed in the presence of 2 simultaneous clinical or
laboratory signs, including leukocytosis (415,000/mm3) or a
X20% increase in leukocytes or CRP. For the present study,
we evaluated CRP in two ways: according to the laboratory
cut-off value (45 mg/L) and in according to the percentage
increase compared with previous values. To determine the
adequacy of the increase in birth weight, we used the
American curve described by Alexander et al. (16). The data
were arranged in a spreadsheet and analyzed using the sta-
tistical program IBM SPSS Statistics 20. Numerical variables
are described as the means, medians, variations (minimum-
maximum), interquartile distributions (25%-75%), and stan-
dard deviations (SDs). Categorical variables are described as
frequencies, percentages and cut-off levels. To compare some
variables with each other, we used the Mann-Whitney U
Test, assuming a level of significance (a) of 5%.
Ethical Aspects
The research project was approved by the department’s
internal committee for the approval of research projects
(CIAPP) and by the Research Projects Approval Committee
(CAPPesq) of the Hospital das Clinicas da FMUSP, with
Technical Advice Number 248040, dated 04/17/2013. It was
registered in the Brazil Platform under the number CAAE
13978413.2.0000.0068. Because it was a retrospective research
project, consent was not necessary; however, care was taken
when handling the patients’ records, and the patients were
not identified. There was no external funding, and the
authors declare no conflict of interest in the publication.
’ RESULTS
In the study period, we identified 418 cases of possible
PPROM. The number of births that occurred in this same
period was 4,669; therefore, a prevalence of 8.95% was
calculated. Of the total deliveries, 2,606 were before the 37th
week. That is, among premature births, the PPROM rate was
16.04%. However, some of those PPROM cases were dis-
charged without return, or the medical record was not found.
Thus, the final analysis included data from 299 pregnant
women who met the inclusion criteria. Their characteristics
are presented in Tables 1 (numerical variables) and 2 (catego-
rical variables).
Some risk factors typically related to the occurrence of
PPROM could be identified, as follows: a history of previous
preterm birth (17.3%); smoking (14%); urinary tract infection
(13.7%); fetal malformation (13.4%); twinning (11.7%); pre-
term labor during the current pregnancy prior to PPROM
(9.9%); diabetes (8.1%); previous PROM (6.6%); bleeding
during the first half of pregnancy (5.8%); cervical incompe-
tence (3.9%); and cerclage (4.3%). In addition, some clinical
and/or obstetric comorbidities were present in 173 pregnant
women (69.2%).
During their initial clinical presentation, these pregnant
women presented typical complaints in 78.2% of the cases,
and diagnostic doubt was present in 17.6% of the cases. In
83.3% of the patients, the diagnosis was confirmed by the
visualization of amniotic fluid in the vaginal sac fundus. The
phenol test was performed in 111 patients (37.1%); the results
were positive in 100 (90.1%), negative in 6 (5.4%), and
unclear in 5 (4.5%). Confirmation with vaginal buffer was
necessary in 11 patients (3.9%). In 35 cases (12.7%), there was
concomitant bleeding in the initial setting, making diagnosis
difficult.
Vaginal cultures at admission were positive in the follo-
wing proportions: Group B streptococcus in 20.2%; fungi in
9.3%; trichomonas in 1.85%; and chlamydia in 1.58% of
patients. No patient was positive for gonococcus. The bac-
terioscopic examinations of vaginal secretions were altered,
with Nugent X4, in 30% of the patients investigated.
Table 1 - Characterization of the sample of 299 pregnant women with PPROM, with numerical variables.
Variable Mean Median Variation (min-max) 25%-75% Standard deviation n
Age (years) 27.46 27.00 14-44 23-32 6.591 299
Initial weight at PNC (kg) 69.73 66.20 44.85-150.0 57.25-77.70 17.67 120
Weight at admission (kg) 73.91 71.70 47.0-154.7 64.10-79.00 15.26 216
Initial BMI at PNC 27.50 26.17 15.33-56.45 22.99-30.73 6.486 116
BMI at admission 29.12 28.10 18.46-58.22 25.32-31.99 5.792 189
Initial GA at PNC 15.69 14.00 4.0-34.0 10-20 6.933 247
GA at diagnosis 31.89 34.00 8.0-36.85 30.85-35.41 5.277 295
GA at admission 32.16 34.14 14.28-36.85 31.00-35.42 4.913 299
Number of prenatal visits 6.01 6.00 0-19 4-8 2.961 259
Abbreviations: GA = gestational age; PNC = prenatal care; BMI = body mass index (kg/m2); n = number. Sao Paulo, Brazil, 2006-2011.
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In terms of the evolution of the condition, 9 patients (3.0%)
progressed to abortion (IGo20 weeks), with a mean GA of
17.32 weeks (SD=1.596) at the time of PPROM and 18.09
(SD=1.852) at the time of elimination of the fetus, which
weighed on average 191 grams (SD=100.42). The latency
period was on average 6.12 days (SD=4.912). Of these 9
patients, 4 (44.4%) had a clinical diagnosis of chorioamnio-
nitis. In the retrospective evaluation, 5 patients (55.5%) were
definitively diagnosed with chorioamnionitis. Despite the
small number of patients, there was a higher rate of chorio-
amnionitis in this subgroup than in the overall sample.
We excluded these nine patients from subsequent evalua-
tions. The remaining 290 patients, who were included in the
analyses described henceforth, evolved as follows.
As can be seen from the analysis in Table 3, during
hospitalization, there was a progressive decrease in amniotic
fluid, as well as increased leukocyte count and CRP. The final
AFI was o5.0, indicating oligohydramnios, in 37.8% of the
cases. There was a decrease in AFI during hospitalization in
72% of the cases, and the final AFI was lower than the
penultimate value in 57% of the patients. There was severe
oligohydramnios (AFIo3) at some point during hospitaliza-
tion in 22.3% of the cases.
A total of 53 patients (23.66%) had leukocytosis (415,000/
mm3) at some point during hospitalization The CRP was
greater than the reference value (o5) in the first evaluation in
63/90 pregnant women (21.6%) and, in the final evaluation,
in 104/164 pregnant women (72.2%). CRP was higher at the
last evaluation than at the first evaluation in 64.8% of the
pregnant women, and this increase was greater than 20% in
54% of patients. When only the last two evaluations were
considered, CRP increased in 70.1% of the patients, and this
difference was greater than 20% in 50.7% of them. The lack of
some data in pregnant women in relation to the Initial CRP
was due to a shorter hospitalization time for these patients.
Separating the groups without and with Initial CRP, a clear
discrepancy is evident: 4.08 vs. 20.11 days, respectively, in
average latency period and 5.9 vs. 16.24 days, respectively, of
hospitalization on average (p=0.000). On the other hand, the
mean birth weight was higher in the group without Initial
CRP (2,232 vs. 1,978 g, p=0.013), as well as a higher mean GA
at delivery (33.95 vs. 32.58 weeks; p=0.001), perhaps because
patients of near GA would not benefit greatly from the CRP
dosage. The same can be said for the cases without and with
Initial AFI, which also had a lower average latency time (4.17
vs. 13.90 days, p=0.000) and a lower mean number of days of
hospitalization (6.13 vs. 12, 02; p=0.000), but with similar
GAs and birth weights.
There was a clinical diagnosis of chorioamnionitis (at least
2 clinical and/or laboratory criteria present at the same time)
in 31 cases (10.8%). In comparison, histological chorioamnio-
nitis was diagnosed through an examination of pathological
anatomy in 71 cases (29%). Overall, the presence of chorio-
amnionitis was observed retrospectively in 55 cases (22.9%).
That is, in 24 cases (8.2% of the total of the pregnant group of
women and 43.6% of the cases with a final diagnosis of
chorioamnionitis), the clinical diagnosis of chorioamnionitis
was only confirmed later and was not initially noticed.
Antibiotics were prescribed before delivery for 61 patients
(29.9%); the most common indications were Group B strep-
tococcus (30 or 15.6%) and urinary tract infection (23 or 10.9%).
Antenatal corticosteroid therapy was used in only 21
patients (9.9%), with a mean GA of 29.94 weeks, ranging
from 24.14 to 34 weeks. In two patients, corticosteroids were
used more than once.
The period of hospitalization for these mothers varied
from 1 to 133 days, with a concentration between 3 and
11 days (25% -75%), a mean of 9.12 days and a median of
5 days. Hospital admission was X7 days in 40.2% of the
patients and was prolonged, X30 days, in only 5.4% of
the sample. The latency period for the group as a whole
ranged from 0 to 145 days; it was concentrated between
Table 2 - Categorical variables characterizing the sample of 299 pregnant women with PPROM.
Variable Number of Cases Category 1 Category 2 Category 3 Category 4
Color 299 White: 173 (57.9%) Brown: 105 (35.1%) Black: 18 (6.0%) Yellow: 3 (1.0%)
Gesta 298 1G: 102 (34.2%) 2G: 67 (22.5%) 3G: 46 (15.4%) 4G: 39 (13.1%)
Para 298 0P: 130 (43.6%) 1P: 74 (24.8%) 2P: 49 (16.4%) 3P: 29 (9.7%)
Abortion 298 0A: 201 (67.7%) 1A: 62 (20.9%) 2A: 18 (6.1%) 3A: 7 (2.4%)
Place of birth 299 SP: 205 (68.6%) BA: 26 (8.7%) MG: 12 (4.0%) PE: 10 (3.3%)
Education level 299 2nd DC: 109 (36.8%) 1st DC: 58 (19.6%) 1st DI: 50 (16.9%) 2nd DI: 45 (15.2%)
Marital status 299 Consensus union: 130 (43.5%) Single: 85 (28.4%) Married: 78 (26.1%) Divorced: 3 (1%)
Occupation 297 Domestic worker: 132 (44.1%) Student: 27 (9.0%) Housemaid: 17 (5.7%) Salesperson: 12 (4.0%)
Local of PNC 298 PNC at HC: 167 (56.0%) Outside HC: 117 (39.3%) No PNC: 14 (4.7%)
Abbreviations: 1st DI: first degree incomplete; 1st DC: first degree complete; 2nd DI: second degree incomplete; 2nd DC: second degree complete;
SP: Sa˜o Paulo; BA: Bahia; MG: Minas Gerais; PE: Pernambuco; PNC = prenatal care. Sao Paulo, Brazil, 2006-2011.
Table 3 - Evolutionary data of 290 pregnant women with delivery in the institution.
Statistics
N Mean Median Std. Deviation Percentiles
Valid Missing 25 50 75
Initial AFI 146 144 8.180 7.300 6.2819 4.575 7.300 10.350
Final AFI 128 162 6.865 6.500 4.4817 3.925 6.500 9.275
Initial Leuko 163 127 11,126.75 10,760.00 3,461.167 9,020.00 10,760.00 12,500.00
Final Leuko 203 87 12,230.10 11,380.00 4,485.653 9,330.00 11,380.00 14,230.00
Initial CRP 90 200 15.32 7.64 21.669 3.75 7.64 15.52
Final CRP 146 144 27.11 10.10 39.916 4.52 10.10 21.90
AFI = Amniotic Liquid Index; Leuko = Leukocyte count; CRP = C Reactive Protein.
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1 and 10 days (25-75%), with a mean of 9.17 and a median
of 2 days. The period between diagnosis and delivery was
X3 days in 48.5%, X7 days in 31.4% and X30 days in 7.9%
of the sample.
Regarding delivery, as shown in Figure 1, more than half
of the patients (160 or 55.2%) spontaneously went into
preterm labor, which was the reason for the interruption of
the pregnancy. More than a quarter of the pregnant women
(79 or 27.2%) had their pregnancy interrupted because they
had reached the 36th gestational week, in accordance with
hospital protocol. Other major causes of discontinuation
were fetal distress (20 cases or 6.9%), a diagnosis of chori-
oamnionitis (17 or 5.9%) and fetal death (4 or 1.4%). Less
frequent causes of discontinuation were cord prolapse
(2 cases or 0.7%), meconium in the amniotic fluid (2),
abruptio placentae (1) and bleeding (1), among others,
totaling 10 cases or 3.4%. Labor was induced on 47 occasions
(16.4%), and misoprostol was used to prepare and ripen the
cervix in 15 cases (5.2%).
The duration of labor for the sample as a whole ranged
from 0 to 96 hours, with an average of 5.06 hours, a median
of 4 hours, and the greatest distribution between 2 and
6 hours (25-75%). More than two-thirds of the patients (154
or 75.9%) had an identified labor duration p6 hours. A foul
smell was present in 30 deliveries of the entire sample (11.6%).
Regarding the type of delivery, the majority of the patients
(159 or 55%) had a cesarean delivery, while 121 (42%) had a
vaginal delivery, and only 10 (3%) required the use of forceps
(Figure 2).
As Figure 3 shows, the indications for cesarean delivery
were almost equally distributed among 4 major factors: fetal
distress; twinning; contraindication for induction (usually
cesarean section); and uncorrected functional dystocia.
Among the 159 cases of cesarean section, the indication for
interruption was preterm labor in 63 cases, fetal distress in 19
cases, chorioamnionitis in 10 cases and PPROM at 36 weeks
in 59 cases. Among the 161 cases where the indication for
resolution was preterm labor, caesarean section occurred in
63 (39.13%), and the indications were as follows: twinning
(19 cases); functional dystocia (9 cases); breech presentation
(8 cases); fetal malformation (6 cases); fetal distress (5 cases);
iterativity (4 cases); maternal pathology (3 cases); uterine
myomatosis (2 cases); previous tumor (2 cases); contracted
pelvis (2 cases); meconium (1 case); cephalopelvic dispropor-
tion (1 case); and HIV (1 case). Among the 79 cases that reached
the 36th week, 59 were submitted to cesarean delivery (rate of
74.68%), and the indications were as follows: contraindica-
tion to induction (16 cases); functional dystocia (11 cases);
iterativity (6 cases); breech presentation (6 cases); twinning
(5 cases); intrapartum fetal distress (4 cases); induction failure
(3 cases); meconium (2 cases); maternal pathology (2 cases);
cephalopelvic disproportion (2 cases); and HIV (2 cases). Of
the total cases, 48 were submitted to induction of labor. Of
these, 20 ended in cesarean delivery (rate of 41.66%). Among
the 18 patients who developed chorioamnionitis, 10 under-
went cesarean delivery (55.55%), with the following indica-
tions: contraindication to induction (4); fetal distress (2);
twinning (1); breech presentation (1); anomalous presentation
(1); and cord prolapse (1).
Among the 290 pregnant women, there were 324 new-
borns, of which 256 were singletons, and 68 were twins.
Viability (GA X26 weeks) was reached by 301 of the fetuses
(92.9%), and almost one-third of the infants (95, 29.32%)
reached the 36th week. However, at delivery, 111 newborns
(34.26%) were less than 34 weeks of GA, and 48 (14.81%)
were less than 30 weeks of GA. The birth weights varied
Figure 2 - Distribution of types of delivery in 290 cases of PPROM,
excluding abortions. Sao Paulo, Brazil, 2006-2011.
Figure 1 - Distribution of causes of pregnancy interruption, in 290 pregnant women with PPROM. Sao Paulo, Brazil, 2006-2011.
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between 280 and 4,170 grams, with the distribution pre-
sented in Figure 4.
There were 250 (78.6%) newborns with adequate weight
for GA (AGA), and 65 (20.4%) were small for gestational age
(SGA), according to the Alexander classification. The rate of
low birth weight (o2,500 grams) was 67%; 18.9% of the
sample weighed less than 1,500 grams, and 10.1% of the
sample weighed less than 1,000 grams. There was a slightly
higher prevalence of female newborns (50.78%) in relation to
males (49.22%).
Approximately one-third of the newborns (117 or 36.9%)
had a 1-minute Apgaro7. At 5 minutes, 48 newborns (15.1%)
scored o7. Acidosis (pHo7.20) was present in the umbilical
cords of 47 newborns (39.2%). The relatively small number of
newborns with cord pH-metry is noteworthy. When checking
the possible associated factors, we found a similar labor time
(5.2 vs. 4.9 hours, p=0.576), but a lower mean GA at delivery
(32.88 vs. 34.57 weeks, p=0.000) and a lower mean birth
weight (2,027 vs. 2,337 grams; p=0.001) for the group without
pH-metry compared to the group with pH-metry, indicating
possible technical difficulties in sample collection. On the
other hand, there were lower Apgar scores in the children
without pH data, in the first minute (6.53 vs. 7.71, p=0.005), the
fifth minute (7.81 vs. 9.04, p=0.008) and even at the tenth
minute (8.17 vs. 9.41; p=0.011), suggesting perhaps a greater
urgency for care.
The analysis in Table 4 presents the numerical variables for
the newborns.
Two hundred eighty-four babies (89% of the sample) were
born alive. Seventeen cases of fetal death occurred, for a
stillbirth rate of 5.33%. Eighteen cases of neonatal death were
reported, for a neonatal mortality rate of 5.64%. Thus, the
perinatal death rate was 35/319=10.97%.
There were complications in childbirth and postpartum in
40 cases (18%), which were distributed as follows: 14 cases of
vaginal and/or cervical lacerations; 4 cases of placental
retention; 3 cases of uterine hypotonia/atony; 3 cases of
increased bleeding; and 2 cases of focal placenta accreta.
Isolated cases of hemoamnion, placental incarceration,
ultimate head in pelvic delivery, corporal cesarean section,
laceration of the uterine segment, cord prolapse, and even
cord rupture were also described. Six patients (2.9%) requi-
red blood transfusion, and 2 (0.9%) required vasoactive drugs.
Endometritis was diagnosed in the puerperium of 7 patients
(3.3%). Sepsis was diagnosed in 2 patients; in one patient, it
progressed to shock. There were no cases of hysterectomy or
maternal death. Clinically, the patient’s general condition was
regular in the puerperium on 7 occasions (2.4%), with malaise
Figure 3 - Distribution of indications for cesarean delivery in 159 pregnant women with PPROM. Sao Paulo, Brazil, 2006-2011.
Figure 4 - Distribution of the weight at birth, in grams, of 324 newborns of mothers with PPROM. Sao Paulo, Brazil, 2006-2011.
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and a visible change in clinical status. Fourteen patients (6.6%)
required intensive observation in the intensive care unit (ICU)
or postanesthetic care unit.
’ DISCUSSION
Because this study was performed at a tertiary hospital
with a large number of patients with comorbidities and a
protocol that leads to pregnancy up to 36 weeks, it differs
somewhat from most other national or international studies.
Maternal age is one potential area of difference; with an ave-
rage of 27.5 years, the maternal age of our patients was similar
to that reported in another hospital in the metropolitan region
of São Paulo among womeno28 weeks pregnant, which was
27.2 years (8). However, the average maternal age of our
subjects was higher than that reported in other Brazilian
studies; those values were 25.4 years in Acre (10), 25.7 years in
Recife (9), 26.0 years in Santa Catarina (17), and 26.7 years in
Rio de Janeiro (7). Maternal age was also higher than that
reported in a Peruvian survey, 26.36 years (18). In contrast, our
patients had a lower average maternal age than those reported
in Pakistan, 30 years (19), Canada, 28.3 years (20), and a
multicenter American study, 29.7 years (21). Such findings
are in agreement with the report of a Brazilian study in
Rio Grande do Sul (22), which accounted for a 2.49-fold higher
risk of PPROM among pregnant women aged 430 years.
Higher maternal age could be related to the more frequent
presence of maternal diseases, such as hypertension and dia-
betes, or obstetric pathologies, such as twinning and fetal
malformations.
However, the mean GA on admission, which was 31.89
weeks (with a median of 34 weeks), appears more com-
patible with the data in the literature. Our findings were
similar to the GA described in 86 pregnant women from
Recife-PE, in the northeastern region of Brazil, 31.9 weeks
(12). However, in the latter study, patients with comorbidities
were excluded, and only women between 24 and 35 weeks of
gestation were included. In addition, our findings differ from
others, such as those from a hospital in ABC Paulista, a
metropolitan region of São Paulo (8), at 21.7 weeks (which
included only patients with a GA o28 weeks), and those
from a hospital in Acre, in the northern region of Brazil (10),
at 34.7 weeks (including term and preterm pregnant women).
Regarding ethnicity, we observed a higher frequency
of PPROM in white pregnant women (57.9%) than in
black women (6%). This finding was similar to data from
Rio Grande do Sul, with a frequency of 69.9% among white
women (22), and the region of ABC Paulista, with 60.6% (8),
but was discordant with some American data, which showed
a greater risk among black women. In fact, a population
cohort of more than 600,000 births in Missouri (23) showed a
higher risk of PPROM among black women than among
white women, with an OR of 2.3 (95% CI: 2.0-2.5). The risk
was even greater for PPROM occurring before 28 weeks of
pregnancy, with an OR of 2.8 (95% CI: 2.5-3.2). However,
another American multicenter study (21) pointed to a predo-
minance of PPROM among white pregnant women (55%).
The education level in our sample was relatively high; the
majority of the patients (57.4%) had an education above
elementary school, and 5.4% were university students. Such
data are contrary to a large proportion of the literature,
which establishes a higher risk of PPROM among women
with less schooling (10,22,24).
Regarding marital status, most of the patients in the pre-
sent study were in a consensual union (43.5%) or were single
(28.4%), and slightly more than one-quarter of them were
married. In comparison, in Acre (10), the rate of single
women was very similar (28.7%), but in Fortaleza-Ceará, in
the Brazilian northeast (11), the rate of single women was
twice as high (66%).
Considering occupation, almost half of the patients ana-
lyzed (44.1%) described themselves as housewives (or as
domestic workers). This rate may appear high, but it is lower
than the rates reported by other authors in Fortaleza-Ceará,
in the Brazilian northeast (11), of 49.7%, or in Cuba (25),
of 71.4%. The latter study found among the housewives a
1.5-fold higher relative risk of PROM after the 30th week of
pregnancy.
Almost all of the patients in this study received prenatal
care, either at our service (56%) or externally (39%), with a
mean number of consultations (six) that was adequate for the
duration of gestation, possibly because of the relatively early
onset of prenatal care (mean GA of 15.69). These data
differed, for example, from the Peruvian situation (18), where
little prenatal control was reported (mean of 2 visits, and
26.7% of the sample did not receive prenatal care).
An important characteristic of our work was the large
number of patients with some comorbidity (69.2%), which
gives it a very specific and unusual profile compared with
other studies because most studies exclude patients with
comorbidities (7,8,9,11,19). Because this was an epidemiolo-
gical study, we considered it important to include such
patients to obtain a better notion of the daily reality of our
hospital, which may be similar to that of others.
Because ours is a tertiary hospital with national referrals in
a state with great migratory flow, it is not surprising that
almost one-third of the patients (31.4%) were from other
states or even other countries, which also distinguishes our
sample from those of other studies.
The mean BMI measured at admission (29.1 kg/m2) or
reported at the first prenatal visit (27.5 kg/m2) revealed a
group of pregnant women who were mildly overweight.
This finding is in line with those of a Chinese study (26) that
included more than two thousand pregnant women and
found a greater risk of PPROM among those with pregravid
overweight. In this study, the PROM rate was progressively
Table 4 - Numerical variables related to birth of 324 newborns of mothers with PPROM.
Variable Mean Median Variation (min-max) 25%-75% Standard deviation n
GA at birth 33.49 34.93 20.81 to 36.86 32.45 to 36.00 3.665 324
Weight at birth 2,124.2 2,240 280 to 4,170 1,750 a 2,640 727.23 319
Apgar 1 min 6.93 8.00 0 to 10 6 to 9 2.845 317
Apgar 5 min 8.29 9.00 0 to 10 8.5 to10 2.616 317
Apgar 10 min 8.67 10.00 0 to 10 9 to 10 2.648 315
Cord pH 7.216 7.226 6.800 to 7.388 7.167 to 7.279 0.094 120
GA = gestational age. Sao Paulo, Brazil, 2006-2011.
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higher with higher pregravid BMI. A study conducted in the
Brazilian northeast (9) reported a mean BMI very similar
to that reported in our work (27.1 kg/m2), but it exclu-
ded patients with hypertension, diabetes and other clinical
diseases.
The frequency of fetal malformations in our population
(13.4%) was relatively high. Another Brazilian study (9)
reported 5 malformations among 159 pregnant women
(3.14%), all of whom were excluded from the final analysis.
We believe that this rate was high in our sample because of
the tertiary profile of the Hospital das Clinicas, which is a
reference center for malformations. In fact, the correlation
between congenital abnormalities per se and PPROM has not
been sufficiently investigated as a result of the exclusion of
such abnormalities in almost all publications on PPROM
(7,8,9,11,19,20).
Twinning is also routinely excluded from research on
PROM. AThai study (27) reported statistically similar PROM
rates for single and multiple pregnancies, although there was
a lower trend among twin pregnancies (5.4%) than among
other pregnancies (9%). However, when we considered the
data of some authors (28) indicating that twinning is present
in 2 to 3% of all pregnant women and constitutes at least 10%
of preterm births, the rate that we identified (11.7%) was
highly significant.
In our patients with PPROM, 8.1% were diagnosed with
diabetes, a rate that appears high but that was lower than the
17.8% rate of gestational diabetes described at the same
service (29) at another time, using new diagnostic criteria.
In contrast, a Brazilian study that included 50 patients with
gestational diabetes treated at a public maternity service in
Ceará, northeastern Brazil, described an overall amniorrhexis
rate of 16% in such patients, higher than the classically
reported rate of 10% (30). Another study from Austria (31)
reported a lower PROM rate followed by spontaneous labor
in pregnant women with diabetes (41.6%) than in the control
group (65.7%). It is possible that this correlation between
diabetes and PROM is related to glycemic control because, as
a study in Spain (32) established, patients whose gestational
diabetes was discovered later presented with higher rates of
polyhydramnios (12.7% vs. 2.1%) and PPROM (2.1% vs. 0%)
than those whose gestational diabetes was discovered earlier.
Our rates of cervical incompetence and cerclage were
relatively high (3.9% and 4.3%, respectively) considering that
the rate of cervical incompetence in the general population
varies between 0.1 and 1.8% (33). However, this finding was
not surprising because PPROM is described as a major
complication of cerclage in cases of cervical incompetence
and occurred in 10.5% of cases in a Brazilian study based in
Campinas (34). Additionally, a case-control study in the
United States (35) showed that patients with PPROM had a
higher frequency of cervical incompetence (6.9%) than
patients in the control group (1.9%), OR=3.8 (95% CI: 1.2-
11.6). This risk was even higher when cervical incompetence
was present in the current pregnancy (14.7% x 1.0% - OR:
18.0; 95% CI: 5.1-63.6) and when the cerclage procedure had
been performed (11.8% x 1.0% - OR=13.9, 95% CI, 3.8-50.4).
We had a relatively high rate of prior abortion: 32.3% of
the sample had at least one abortion. Some authors (35) have
described a history of abortion or pregnancy loss up to 20
weeks in 52.9% of their patients with PPROM, which clearly
differed from that of the control group (33.5%). Other authors
have described an association between PPROM and repeated
abortions. Israeli authors (36), for example, reported a relative
risk of 1.2 (95% CI: 1.1-1.3) for PPROM among patients with
repeat abortions, with an incidence of 6.5% vs. 5.6% in the
control population. Another Israeli study (37) reported even
higher rates of repeat abortion among those with PPROM
(9.4%), surpassing the prematurity group; in comparison, the
rate among those without PPROM was 6.9%. In comparison,
an American study (38) described increasing rates of PPROM
according to the previous history of fetal loss: the rate was
2.6% in the absence of an antecedent, 3.2% when there was
only one loss, 5.1% when there were two losses and 6.7%
when there were 3 or more losses.
We also found high personal background rates of preterm
birth (17.3%) and previous PPROM (6.6%) that were clearly
higher than rates for the general population, but not as high
as those reported in one American study (35), in which 26.6%
experienced preterm delivery in the second trimester (OR
16.1), and 22.5% experienced preterm delivery in the third
trimester (OR=3.2). These American authors also established
a rate of 11.8% for previous PPROM; this rate was higher
than the rate of 1.6% reported for the control population,
thus yielding an OR=8.3. However, our rates are still higher
than those indicated by a survey carried out in the Brazilian
northeast (11), where 5.4% of pregnant women with PPROM
had a history of PPROM, and 4.8% had previous prematur-
ity. A classic study on the subject (39) previously indicated
that previous premature birth was an important risk factor
for PPROM, with OR=2.5.
We found a history of genital bleeding in the first half of
pregnancy in 5.8% of the patients, a rate that may have been
underestimated given the retrospective nature of this study
but was otherwise significant. Some authors have presented
higher rates, such as 9.8% (35), and others have reported
lower rates (1.3%), but with an increased risk compared with
the control group: OR 2.44 (37). Some studies have even cited
a 7-fold increased risk for PPROM when genital bleeding is
present (39).
The rate of smoking (14%) in the sample was also
significant. It was higher than that reported in some Brazilian
studies of smoking prevalence in pregnant women, such as
the 4.1% rate reported for women in São Luis, Maranhão, in
northern Brazil (40). Although some more recent authors
(41) have not been able to identify a difference in the smo-
king rate between pregnant women with PPROM (28.9%)
and those without it (26.84%), most authors assume an asso-
ciation between smoking and PROM, with at least double the
risk of PROM among smokers (35,39,42,43).
Few studies have adequately described the initial clinical
presentation of and the diagnostic methods for PPROM. We
will compare our data with those of some Brazilian studies.
The first study, conducted in Ribeirão Preto-SP in the
southeastern part of the country (44), reported that fluid
loss was present in 42% of the 107 cases evaluated, while we
described it as a typical flow of liquid in 78.2% of the cases.
Another study (45) of 29 pregnant women with PPROM at
o26 weeks stated that the diagnosis was clinically confirmed
by specular examination in 62.1% of the cases (in our study,
clinical confirmation occurred in 83.3% of cases), and 31%
had concomitant vaginal bleeding (in our data, this sign was
only present in 12.7% of pregnant women). A study from
Rio de Janeiro (7) reported that the diagnosis was confirmed
by vaginal pH analysis using nitrazine paper and by
observing arboriform crystallization of the liquid collected
in the vaginal sac fundus, but it did not establish the rates of
use of such procedures. In fact, most international studies
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also fail to describe in detail how the diagnosis was made. In
this sense, the present study, which describes in detail how
PPROM was diagnosed, has some relevance. It is known that
PROM is easier to diagnose at term, when a large amount of
amniotic fluid can be observed on pelvic examination. How-
ever, the lower the GA, the greater the difficulty of estab-
lishing the diagnosis because the amount of amniotic fluid
that is externalized is lower. In our series, there was diagnostic
doubt in 17.6% of the cases, and even the phenol test did not
confirm the diagnosis in approximately 10% of the analyzed
pregnant women. That is, diagnosis is difficult in clinical
practice in many situations, which may lead to an increase
in infection risk for the maternal-fetal pair. This situation
indicates a gap that needs to be filled with more reliable tests.
Leukocytes - In the present study, the mean leukocyte
count observed at admission was 11,173/mm3, with 9.5%
leukocytosis. These rates are lower than those reported by
the majority of authors (17,44,46,47) but higher than some
reports (48).
CRP - In the present study, CRP presented a mean initial
value of 15.96 mg/L, which is very close to the value of 14.80
mg/L reported in a Turkish study (46) but higher than the
8.37 mg/L at entry reported in an Italian study (47).
Chorioamnionitis - Our described rate of 10.8% for prep-
artum clinical chorioamnionitis is relatively low, even
considering the final chorioamnionitis rate of 22.9%. In fact,
most of the papers analyzed reported higher rates: 23.9%
(18), 34.7% (9), 35% (46), 47% (8), 53% (47), and 67.1% (7).
However, there were also studies with comparatively lower
rates: 20.2% (49); 17.4% (21); 16.5% (37), 14.6% (10); 12% (19);
9% (20); and 2.4% (11). However, in the latter case (11),
only 29.7% of the sample had PPROM, and the great majority
were 437 weeks of gestation. In addition, 18.8% of the
newborns were diagnosed with infection, which suggests that
the actual rate of maternal infection must have been higher.
AFI - Our mean initial AFI was 8.1 cm, higher than the
initial averages reported by some Brazilian authors: 3.9 cm
(8) and 3.7 cm (12). A total of 27.9% of our patients had
oligohydramnios at the initial evaluation, which was also
lower than the rates reported by the majority of the authors
analyzed [75.8% (45), 62.3% (46), 60.8% (9), 52.7% (50)] but
higher than those reported in articles from other countries
[China, 12.8% (51); and Israel, 4.3% (37)]. However, in China,
only 11.2% of the cases were born preterm; in Israel, most
cases (80.8%) were born between 33 and 36 weeks.
Vaginal Infections - Our Group B streptococcus detection
rate (20.2%) was lower than that reported in southeast Brazil,
in Campinas (52), 30%, but higher than the 14.8% reported in
Spain (53). A rate of 14.8% was also described in another
Brazilian article (54), but with normally progressing women
in the third trimester of pregnancy, without rupture of mem-
branes. A recent Chinese case-control article (55) identified
Group B streptococcal infection as a risk factor for PROM,
with rates of 22.3% in cases and 6.5% in controls. Interest-
ingly, this rate was quite similar to our data. We also
identified a 30% rate of bacterial vaginosis in our PPROM
patients. This rate is similar to that presented by Nigerian
authors for pregnant women with term PROM (56): 29.1%.
However, our rate was substantially lower than that found
by Japanese authors (57) in pregnant women with preterm
labor who eventually evolved to PPROM: 72.9%.
Corticoids - The rate of corticosteroid use in this sample
was close to 10%. Despite the wide variation among various
authors, our rate is among the lowest; other studies have
reported rates of 98% (9), 94.45% (17), 62.8% (25), 51.5% (8),
45% (21), 33.3% (10), 18.8% (11), 18.7% (44), and 6.9% (45). In
contrast, a Canadian study (20) showed variable rates of
corticosteroid use depending on the latency period, ranging
from 31% (latency o48 hours) to 68.5% (latency X7 days).
Latency - The latency period averaged 9.17 days, with a
duration of X3 days in almost half of the cases. Of course,
this variable depends greatly on the population studied and
the hospital’s protocol. If we had excluded patients with twin
gestation, malformed fetuses or comorbidities, the latency
period would certainly have been greater. The GA at diag-
nosis is also very relevant. A Brazilian study (11) in which
the majority of cases were above 37 weeks of gestation had
an average latency period of only 42 hours, with durations of
p24 hours in 65.5% of the sample. In comparison, cases of
PPROM before viability had a longer latency period, from
21.7 days (45) to 12 days (8); the latter paper reported a
latency period o7 in only 7.6% of the cases. A Brazilian
study from Santa Catarina, in the south of Brazil (17), with a
slightly longer GA (20 to 33 weeks) reported a mean latency
time of 12 days, with 54.5% of cases surpassing 7 days of
latency. Canadian researchers (49) also reported an average
latency of 12 days in patients hospitalized for PPROM.
In studies that included a sample similar to ours, at least in
terms of GA, the mean latency periods were similar:
10.5 days (9) and 10.68 days (18). A Brazilian study from
Rio de Janeiro (7) reported a latency period of 448 hours in
66.5% of cases, which was slightly better than our results.
The results of one Italian study (47) were also better, with an
average latency period of 16 days. However, several authors
reported worse data: a mean latency of approximately 3 days
(46) and a latency period o24 hours in 69.2% of the sample,
even when the GA at rupture was between 21 and 37 weeks
(44). A Canadian study (20) presented similar results, with
median latency periods of 87.6 hours (3.6 days) for the group
with a GA between 24 and 34 weeks and 22.8 hours in the
group with a GA between 34 and 36 weeks.
Our rate of urinary tract infection (UTI) during pregnancy
was 13.7%. A Brazilian article from the Amazon region (58)
that included 100 puerperae with preterm births had a
PPROM rate of 15.6%, and 21.8% had clinically diagnosed
UTI during prenatal care. Another national article, from Rio
Grande do Sul (22), did not perceive an increased risk of UTI
in pregnant women with PPROM compared with control
patients; the rates were 3.4% in the former and 2.9% in the
latter. However, other case-control studies observed signifi-
cant differences. One of them, from India (59), described a
history of UTI in 6% of patients with PROM and in 2%
of control patients, with OR=3.5 (1.05-14.9). Another study
from Cuba (60) found a significant relative risk of 1.33
(1.15-1.53), with a UTI rate of 14.7%, very similar to ours.
A third study, from Israel (37), also found an increased risk
(OR=1.55) of UTI in patients with PPROM (5.1%) compared
with other patients with preterm delivery but without PROM
(3.3%).
Type of delivery - We had a cesarean rate of 55%, which is
the average rate at our institution in recent years. These
numbers are similar to the cesarean rates described in works
from Italy (47), with 57.5%; the United States (21), with
57.4%; Iran (50), with 56%; Cuba (25), with 48.5%; and
Canada (49), with 48.3%. Some studies (11,18) show higher
cesarean rates of close to 72-74%. In contrast, some authors
(7,8,9,20,24,42,44) had lower cesarean delivery rates, ranging
from 14 to 39%. In view of the previously described con-
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ditions of our population, we consider our cesarean rate
adequate and comparable to that of other authors in similar
situations. It is worth noting that our cesarean rate was due
in large part to the presence of previous uterine scarring,
which in our service contraindicates the induction of labor. In
cases with spontaneous labor, the cesarean rate was only
39%, the main indications were twinning and pelvic presen-
tation. In the cases that reached the 36th week, the cesarean
rate was higher (almost 75%), the main indications being
contraindication to induction (usually the presence of an
anterior cesarean section), functional dystocia and iterativity
(two or more cesareans). That is, our very high cesarean rate
is related not only to the PPROM itself, but also to the demo-
graphic characteristic of our population, with high rates of
previous cesarean section.
Indication for delivery - The main indications for the cesa-
rean sections performed in our sample were fetal distress,
contraindications for induction (usually because of previous
cesarean section), functional dystocia and pelvic presenta-
tion, excluding cases of twinning and fetal malformation. It is
difficult to compare other studies with ours because few
authors have clarified the reasons for selecting a specific type
of delivery and because differences in obstetric protocol
hamper interpretation. The presence of comorbidities in
more than half of our sample raises the risk of fetal distress,
which was not reported in other studies. However, we can
comparatively analyze some studies. One study (47) descri-
bed similar indications, with changes in cardiotocography
(52.6%), followed by noncephalic fetal presentation (21%).
The latter was the main indication reported by another group
of investigators (8) for the upper route (42.4%), followed by
previous cesarean section and fetal distress (19.2% each). Ina
Cuban survey (25), the main indication was induction failure
(35.1%), followed by anhydramnios and ovular infection
(23.6% each). Similarly, signs of intrauterine infection were
the main reason for cesarean section reported by other
authors (44); such signs occurred in 40.9% of cases.
Induction of labor - Certainly, maintaining the pregnancy
until the 36th week increases the chance of spontaneous labor
(which was present in 55% of our patients) and reduces the
rate of resolution by the induction of labor, which occurred in
16.4% of our sample. Virtually all other authors reported
higher rates of induction: 22.7% (8); 28.6% (25); 32.4% (9);
and 62.6% (44). The only perceived exception was an Israeli
study (37) of pregnant women with PPROM up to 36 weeks,
which described an 8% rate of induction with oxytocin and a
3% rate of induction with vaginal prostaglandin. These rates
were higher than those for the control group of pregnant
women who had preterm birth without PROM: 3.3% and
6.1%, respectively.
Intercurrences at delivery and postpartum - We noted
some intercurrences at delivery and postpartum in 18% of
the sample, most of which were routine intercurrences, such
as laceration of the birth canal. If we did not consider this
occurrence, we would have had a lower rate of 8.9%. The
main intercurrences were endometritis (3.3%); bleeding
during the 3rd and 4th periods (3.1%), which required blood
transfusion in 2.9% of cases; and a 0.7% rate of maternal
sepsis. Our data are better than most reports in the literature.
We only identified one Israeli study (37) with a lower rate of
endometritis (2.8%) than ours, but this rate was higher than
that of the control group, which had preterm delivery but
without PROM (1.4%). However, these authors described
other complications during childbirth, such as placental
retention requiring the manual removal of the placenta
(2.1%), wall infection (2.1%) and bacteremia (9.4%), which
resulted in an overall complication rate of 16.4%. In Peru
(18), a 10.6% rate of infection at the operative site, a 2.1% rate
of maternal sepsis, and a 2.8% rate of abruptio placentae with
bleeding were described, while in Cuba (25), an endometritis
rate of 8.57% was reported. In comparison, in Pakistan (24),
the authors reported a rate of 16.5% for infectious complica-
tions. In Canada (49), some maternal morbidity was des-
cribed in 59.6% of patients hospitalized for PPROM, with a
22.7% rate of antepartum hemorrhage. In Iran (50), a 16.5%
rate of hemorrhagic complications at delivery was reported.
In Brazil, authors (45) have reported a 17.2% rate of post-
partum infectious disease, in addition to a 3.4% rate of
postpartum hemorrhage, while others (44) described only a
1.8% rate of postpartum endometritis but a 14.2% rate
of fever in the immediate puerperium, in addition to one
maternal death (0.93%). We believe that the comparatively
lower rate of puerperal complications in our data was
associated with our hospital’s policy of expectant manage-
ment, which involved lower rates of induction and operative
delivery. This reasoning is supported by the findings of a
Dutch research group (61), where patients who underwent
active management showed a tendency toward an increased
risk of maternal sepsis and a reduced risk of neonatal sepsis,
with a significant increase in the rate of neonatal fever,
compared with patients treated with expectant management.
A similar pattern can be observed in study data from a
Pennsylvania hospital (62), which, by changing the service
protocol so that the resolution of PPROM cases was antici-
pated at 34 weeks rather than 36 weeks, observed increased
rates of chorioamnionitis (from 3.4 to 8%), endometritis (from
0 to 4%) and cesarean section (from 20.7 to 44%).
Days of hospitalization - In our sample, the mean number
of days of maternal hospitalization was 9.18 days; it wasX7
in 40.2% of cases. This average was lower than that reported
by the majority of the other authors: 13.6 days (9); 15.3 days
(18); and 19.1 days (8). A Canadian study (49) that compared
hospital care with home care reported an average length of
hospital stay of 14 days for the hospital group.
Birth weight - Our data indicated a mean birth weight of
2,124 grams; 67% of newborns were low birth weight (LBW),
18.9% weighed less than 1,500 grams (very low birth weight -
VLBW), and 20.4% of the sample was SGA. Comparisons
with other reports highlight our good results. An exception
was a Pakistani study (24), which reported better indexes
than ours, including an LBW rate of 62.3% and a VLBW rate
of 11.76%. A multicenter Chinese study (51) that included
newborns between 26 and 36 weeks GA indicated a mean
birth weight similar to that of our study but slightly lower;
the mean was 1,997 grams, but the sample showed wide
variation (ranging from 700 to 3,900 grams). Other studies
had worse numbers, such as a recent Iranian study (50) that
indicated mean birth weights of 1,730 grams in the normal
AFI group and 1575 grams in the group with oligohydram-
nios. A recent Canadian study (49) reported a median weight
of 1,807 grams for infants born to patients hospitalized for
PPROM, but only 4.5% of the infants showed fetal weight
restriction. Three studies reported mean birth weights lower
than ours but included GAs up to 34 weeks: 1,653 grams (18),
1,725 grams (17), and 1,483 grams (7). A Cuban study (25)
that also included patients with PPROM up to 34 weeks
reported that all newborns were underweight (o2,500 g),
and 47.3% weighedo1,500 grams. A study from the Brazilian
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northeast (9) reported follow-up data up to 35 weeks, with an
average birth weight of 1,711 grams and a high LBW rate of
90.2%. In comparison, Israeli research (37) that included 968
pregnant women up to 36 weeks reported that 66.7% of
newborns weighed p2,500 grams, but only 3.4% had fetal
growth restriction. Other studies described a case-series of
patients with PPROM before viability and showed an even
more unfavorable picture: an average weight of 1,324 grams,
with an 87.8% rate of LWB (8) and a 17.2% rate of SGA (45).
GA at delivery averaged 33.49 weeks, with 38.9% of
patients reaching 36 weeks. This good result was related to
the casuistry studied, which described cases up to the limit of
late prematurity. Few studies have focused on this broader
GA profile. A multicenter Chinese study (51) is one of the
few studies presenting PPROM results up to 36 weeks; it
reported a mean GA at delivery of 32.4 weeks, ranging from
24 to 36 weeks. Other studies have not evaluated late pre-
maturity; therefore, they had lower GAs at birth: 32.3 weeks
(46); 31.7 weeks (7); 28.4 weeks (8).
Apgar scores - Our data indicate that 31.8% of newborns
had 1-min Apgar scores o7, while only 11.2% had 5-min
Apgar scoreso7. Again, our data demonstrate better results
than those of most authors, possibly because of the higher
GA of our sample. Studies of participants with higher GA at
delivery had better rates: 1-min Apgar scoreo5 in 12.3% and
5-min Apgar score o7 in 3.8% (37); 5-min Apgar scores p7
in 4.8% of newborns (11); 1-min Apgar scores o7 in 34.5%
and 5-min Apgar scoreso7 in 9.8% (18). An American study
(21) that included pregnant women with GAo32 weeks and
excluded twins reported intermediate rates: 7.7% had 5-min
Apgar scoreso5. A Canadian study that included more than
four thousand pregnant women with PPROM (20) presen-
ted two different rates for Apgar scores: when the GA was
between 24 and 34 weeks, 5-min Apgar scores o7 occurred
in 6.7% of patients, while for GAs between 34 and 36 weeks,
the rate was only 1.4%. Other authors whose samples had a
lower GA described more worrisome numbers: 1-min Apgar
scores o7 in 51% of the newborns and 5-min Apgar scores
o7 in 12.2% (8); 5-min Apgar scores o7 in 17.9% (7); 1-min
Apgar scores o7 in 37.9% (25) and low 1-min Apgar scores
in 30.5% (24); and finally, 1-min Apgar scores with a median
of 7 (interquartile range 4-9) and 5-min Apgar scores with a
median of 9 (interquartile range 8-9) (9).
Perinatal mortality - For our entire series, which included
malformed and twin fetuses, we obtained a stillbirth rate of
5.33%, which, together with the neonatal mortality rate of
5.64%, yields a perinatal mortality rate of 10.97%. If, like
most authors, we had excluded these higher-risk subgroups,
we would have had better indexes (3.7% neonatal mortality,
4.2% stillborn mortality, and 7.9% perinatal mortality). In any
case, compared with the results of other authors, our results
appear favorable. While a Cuban study (25) had better rates
(2.63%) for stillbirths and the same rate of neonatal mortality,
for a total perinatal mortality rate of 5.26%, other studies
computed worse rates. An American study (21) reported
3.22% stillbirths (half of them in the delivery room) and 7.1%
neonatal mortality, for a total perinatal death rate of 10.32%,
but this study excluded twin pregnancies and births at 432
weeks. An Israeli study (37) with a population similar to ours
that included pregnant women up to 36 weeks of gestation
reported a fetal mortality rate of 1.75% (including an 0.8%
rate of intrapartum death) and a neonatal death rate of 5.5%,
resulting in a perinatal mortality rate of 7.23%. A Pakistani
study (24) reported a fetal death rate of 5.8% and a neonatal
death rate of 12.9%, yielding a perinatal death rate of 18.8%.
An Iranian study (50) reported a neonatal death rate of
14.3%, which was significantly higher when the AFI waso5,
with an RR=6. Brazilian studies have also reported discoura-
ging indexes; the exception was one study that had a pre-
dominance of patients close to term (11) and reported a
neonatal death rate of only 1.2%. The others presented the
following results: 25.7% fetal deaths and 16.7% neonatal
deaths, totaling 42.4% (8); neonatal deaths in 14.45% (7);
a stillbirth rate of 4.54% and a neonatal mortality rate of
13.63%, totaling 18.17% (17); and 10.3% fetal deaths and
86.2% neonatal deaths, with a very high perinatal mortality
rate of 96.5% (45). To better illustrate the important influence
of weight and GA on perinatal mortality, one Brazilian study
(9) reported a total perinatal mortality rate of 29%, which
reached 100% when the newborn’s weight wasp1,000 grams
and zero when the weight was 42,500 grams.
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